Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation: insights from the ARISTOTLE trial

被引：0
|
作者：
Bahit, M. C. [1 ]
Lopes, R. D. [2 ]
Wojdyla, D. M. [2 ]
Held, C. [3 ]
Hanna, M. [4 ]
Vinereanu, D. [5 ]
Goto, S. [6 ]
Alexander, J. H. [2 ]
Wallentin, L. [3 ]
Granger, C. B. [2 ]
机构：
[1] INECO Neurociencias, Rosario, Santa Fe, Argentina
[2] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27706 USA
[3] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[4] Bristol Myers Squibb Co, Princeton, NJ USA
[5] Univ Med & Pharm Carol Davila, Bucharest, Romania
[6] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1973
引用
收藏
页码：338 / 339
页数：2
相关论文
共 50 条
  • [41] Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Granger, Christopher B.
    Lopes, Renato D.
    Hanna, Michael
    Ansell, Jack
    Hylek, Elaine M.
    Alexander, John H.
    Thomas, Laine
    Wang, Junyuan
    Bahit, M. Cecilia
    Verheugt, Freek
    Lawrence, Jack
    Xavier, Denis
    Wallentin, Lars
    [J]. AMERICAN HEART JOURNAL, 2015, 169 (01) : 25 - 30
  • [42] Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Avezum, Alvaro
    Lopes, Renato D.
    Schulte, Phillip J.
    Lanas, Fernando
    Gersh, Bernard J.
    Hanna, Michael
    Pais, Prem
    Erol, Cetin
    Diaz, Rafael
    Cecilia Bahit, M.
    Bartunek, Jozef
    De Caterina, Raffaele
    Goto, Shinya
    Ruzyllo, Witold
    Zhu, Jun
    Granger, Christopher B.
    Alexander, John H.
    [J]. CIRCULATION, 2015, 132 (08) : 624 - 632
  • [43] Relationship Between Body Weight and Pharmacokinetics of Apixaban in Patients With Atrial Fibrillation: Insights from the ARISTOTLE Trial
    Harrington, Josephine
    Giczewska, Anna
    Wojdyla, Daniel
    Washam, Jeffrey B.
    Fudim, Marat
    Hijazi, Ziad
    Lopes, Renato D.
    Hylek, Elaine
    Hohnloser, Stefan H.
    Goto, Shinya
    Bahit, Maria
    Wallentin, Lars C.
    Granger, Christopher B.
    Alexander, John H.
    [J]. CIRCULATION, 2021, 144
  • [44] Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
    Guimaraes, Patricia O.
    Pokorney, Sean D.
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Gersh, Bernard J.
    Giczewska, Anna
    Carnicelli, Anthony
    Lewis, Basil S.
    Hanna, Michael
    Wallentin, Lars
    Vinereanu, Dragos
    Alexander, John H.
    Granger, Christopher B.
    [J]. CLINICAL CARDIOLOGY, 2019, 42 (05) : 568 - 571
  • [45] USE OF INTERACTING DRUGS DID NOT MODIFY TREATMENT EFFECTS OF APIXABAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL
    Washam, Jeffrey B.
    Hohnloser, Stefan
    Wojdyla, Daniel
    Vinereanu, Dragos
    Alexander, John
    Lopes, Renato
    Gersh, Bernard
    Hanna, Michael
    Horowitz, John
    Hylek, Elaine M.
    Husted, Steen
    Xavier, Denis
    Verheugt, Freek W. A.
    Wallentin, Lars
    Granger, Christopher
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 442 - 442
  • [46] Risk of major bleeding among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban, or warfarin in the US Medicare population
    Amin, A.
    Keshishian, A.
    Trocio, J.
    Dina, O.
    Le, H.
    Rosenblatt, L.
    Mardekian, J.
    Zhang, Q.
    Baser, O.
    Liu, X.
    Vo, L.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 964 - 964
  • [47] Anemia Predicts Bleeding and Mortality, but Not Stroke, in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
    Westenbrink, B. Daan
    Alings, Marco
    Granger, Christopher B.
    Alexander, John H.
    Lopes, Renato D.
    Thomas, Laine
    Wojdyla, Daniel M.
    Hanna, Michael
    Keltai, Matyas
    Steg, P. Gabriel
    De Caterina, Raffaele
    Wallentin, Lars
    van Gilst, Wiek
    [J]. CIRCULATION, 2014, 130
  • [48] A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism
    Schaefer, Jordan K.
    Errickson, Josh
    Kong, Xiaowen
    Ali, Mona A.
    Chipalkatti, Naina
    Haymart, Brian
    Kaatz, Scott
    Krol, Gregory D.
    Sood, Suman L.
    Froehlich, James
    Barnes, Geoffrey D.
    [J]. BLOOD, 2023, 142
  • [49] Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial
    Al-Khatib, Sana M.
    Thomas, Laine
    Wallentin, Lars
    Lopes, Renato D.
    Gersh, Bernard
    Garcia, David
    Ezekowitz, Justin
    Alings, Marco
    Yang, Hongqui
    Alexander, John H.
    Flaker, Gregory
    Hanna, Michael
    Granger, Christopher B.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (31) : 2464 - 2471
  • [50] Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time Insights From the ARISTOTLE Randomized Clinical Trial
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Andersson, Ulrika
    Alexander, John H.
    Hanna, Michael
    Keltai, Matyas
    Parkhomenko, Alexander
    Lopez-Sendon, Jose L.
    Lopes, Renato D.
    Siegbahn, Agneta
    Granger, Christopher B.
    Wallentin, Lars
    [J]. JAMA CARDIOLOGY, 2016, 1 (04) : 451 - 460
12345